`
`NOTE: This order is nonprecedential.
`
`United States Court of Appeals
`for the Federal Circuit
`______________________
`
`MERCK SHARP & DOHME B.V., MERCK SHARP &
`DOHME, LLC,
`Plaintiffs-Appellees
`
`v.
`
`AUROBINDO PHARMA USA, INC., AUROBINDO
`PHARMA LTD., USV PRIVATE LIMITED, GLAND
`PHARMA LIMITED, MANKIND PHARMA LTD.,
`LIFESTAR PHARMA LLC, FRESENIUS KABI USA,
`LLC, DR. REDDY'S LABORATORIES, INC., DR.
`REDDY'S LABORATORIES, LTD., SUN
`PHARMACEUTICAL INDUSTRIES, INC., SUN
`PHARMACEUTICAL INDUSTRIES LIMITED,
`SANDOZ INC., LEK PHARMACEUTICALS, D.D.,
`MYLAN API US LLC, MYLAN PHARMACEUTICALS
`INC., MYLAN INC., EUGIA PHARMA SPECIALTIES
`LIMITED,
`Defendants-Appellants
`
`LUPIN LTD., LUPIN PHARMACEUTICALS, INC.,
`LUPIN INC., TEVA PHARMACEUTICALS USA,
`INC.,
`Defendants
`______________________
`
`2023-2254
`______________________
`
`
`
`
`
`
`
`
`Case: 23-2254 Document: 49 Page: 2 Filed: 11/08/2023
`
`
`
` MERCK SHARP & DOHME B.V. v. AUROBINDO PHARMA USA, INC. 2
`
`Appeal from the United States District Court for the
`District of New Jersey in Nos. 2:20-cv-02576-CCC-LDW,
`2:20-cv-02750-CCC-MF, 2:20-cv-02751-CCC-MF, 2:20-cv-
`02786-CCC-MF, 2:20-cv-02787-CCC-MF, 2:20-cv-02892-
`CCC-MF, 2:20-cv-02909-CCC-MF, 2:20-cv-02964-CCC-MF,
`2:20-cv-03007-CCC-MF, 2:20-cv-03068-CCC-MF, 2:20-cv-
`03072-CCC-MF, 2:20-cv-03112-CCC-MF, 2:20-cv-03117-
`CCC-MF, 2:20-cv-03270-CCC-MF, 2:20-cv-03314-CCC-MF,
`and 2:20-cv-03795-CCC-MF, Judge Claire C. Cecchi.
`______________________
`
`ON MOTION
`______________________
`
`O R D E R
`Teva Pharmaceuticals USA, Inc. moves to “withdraw
`
`as Appellant and a named party from this appeal.” ECF
`No. 44 at 4.
`
`Practice Note to Federal Circuit Rule 12 provides that
`“[i]t is the court’s usual practice to include in the official
`caption all parties participating in the court below at the
`time of entry of judgment, even if they are not participating
`in the appeal.”
` Upon consideration thereof,
`
`IT IS ORDERED THAT:
`
`(1) The motion is granted to the extent that the official
`caption is revised as reflected herein.
`(2) The Clerk of Court shall transmit a copy of this
`
`
`
`
`
`
`
`
`
`
`
`Case: 23-2254 Document: 49 Page: 3 Filed: 11/08/2023
`
`MERCK SHARP & DOHME B.V. v. AUROBINDO PHARMA USA, INC. 3
`
`
`
`order to the merits panel assigned to this case.
`
`
`FOR THE COURT
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`November 8, 2023
` Date
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`